REGN REGENERON PHARMACEUTICALS
FollowStock (common), issuer CIK 872589
1,212 managers (1,245 13F filers) reported a position in REGN shares at 2025-09-30, 87,093,394 shares in all. 158 filers opened a position and 111 filers sold out during the quarter.
- Managers
- 1,212
- 13F filers
- 1,245
- New
- 158
- Added
- 487
- Reduced
- 418
- Sold out
- 111
- Shares held by filers
- 87,093,394
Shares held by filers adds up every 13F filer's report, so a share reported by a parent and by its subsidiary counts twice (H9). Managers counts each filer group once.
13D and 13G filers
No 13D or 13G on this security in the data. Structured 13D/G data starts 2024-12-18.
Insider trades
| Owner | Date | Shares | Price | Filing |
|---|---|---|---|---|
| MURPHY ANDREW Jofficer (Co-Chief Scientific Officer) | 2026-10-14 | -50 S | $781.47 | Form 4 |
| MURPHY ANDREW Jofficer (Co-Chief Scientific Officer) | 2026-10-14 | -463 S | $780.63 | Form 4 |
| MURPHY ANDREW Jofficer (Co-Chief Scientific Officer) | 2026-10-14 | -380 S | $779.59 | Form 4 |
| MURPHY ANDREW Jofficer (Co-Chief Scientific Officer) | 2026-10-14 | -454 S | $778.64 | Form 4 |
| MURPHY ANDREW Jofficer (Co-Chief Scientific Officer) | 2026-10-14 | -38 S | $777.76 | Form 4 |
| MURPHY ANDREW Jofficer (Co-Chief Scientific Officer) | 2026-10-14 | -66 S | $776.31 | Form 4 |
| MURPHY ANDREW Jofficer (Co-Chief Scientific Officer) | 2026-10-14 | -376 S | $775.46 | Form 4 |
| MURPHY ANDREW Jofficer (Co-Chief Scientific Officer) | 2026-10-14 | -121 S | $774.48 | Form 4 |
| MURPHY ANDREW Jofficer (Co-Chief Scientific Officer) | 2026-10-14 | -224 S | $773.4 | Form 4 |
| MURPHY ANDREW Jofficer (Co-Chief Scientific Officer) | 2026-10-14 | -211 S | $772.56 | Form 4 |
| MURPHY ANDREW Jofficer (Co-Chief Scientific Officer) | 2026-10-14 | -283 S | $771.56 | Form 4 |
| MURPHY ANDREW Jofficer (Co-Chief Scientific Officer) | 2026-10-14 | -12 S | $770.2 | Form 4 |
| MURPHY ANDREW Jofficer (Co-Chief Scientific Officer) | 2026-10-14 | -127 S | $769.3 | Form 4 |
| MURPHY ANDREW Jofficer (Co-Chief Scientific Officer) | 2026-10-14 | -105 S | $768.33 | Form 4 |
| MURPHY ANDREW Jofficer (Co-Chief Scientific Officer) | 2026-10-14 | -192 S | $767.39 | Form 4 |
13F holders, Q3 2025
Filers in the available 13F reports with a share position at 2025-09-30, filer groups collapsed to one row (method), largest first. Options and principal amounts are left out. A group row states no % of portfolio, since each member reports its own portfolio: the members' percents are listed under it. A value about 1,000 times or 1/1,000 of the price other filers imply is shown as filed but neither ranks the row nor enters a sum.
| Holder | Shares | Value | % of portfolio | Change | Source |
|---|---|---|---|---|---|
| Palisade Asset Management, LLC | 1 | $563 | <0.01% | new | 13F-HRTimeline |
| Quaker Wealth Management, LLC | 1 | $563 | <0.01% | -1 | 13F-HRTimeline |
| Avalon Trust Co | 1 | $563 | <0.01% | -49 | 13F-HRTimeline |
| Delos Wealth Advisors, LLC | 1 | $563 | <0.01% | 0 | 13F-HRTimeline |
| Breakwater Investment Management | 1 | $563 | <0.01% | new | 13F-HRTimeline |
| WINNACLE WEALTH LLC | 1 | $563 | <0.01% | new | 13F-HRTimeline |
| MOTCO | 1 | $562 | <0.01% | 0 | 13F-HRTimeline |
| N.E.W. Advisory Services LLC | 1 | $562 | <0.01% | 0 | 13F-HRTimeline |
| Davis Capital Management | 1 | $562 | <0.01% | 13F-HRTimeline | |
| HFM Investment Advisors, LLC | 1 | $562 | <0.01% | 0 | 13F-HRTimeline |
| Quest 10 Wealth Builders, Inc. | 1 | $337 | <0.01% | 0 | 13F-HRTimeline |
| Y.D. More Investments Ltdin group Y.D. More Investments Ltd | 28 | $47 | new | 13F-HRTimelineGroupValue about 1/1,000 of the price other filers imply, kept as filed and left out of ratios. |
Events
MURPHY ANDREW J reported transactions in REGN shares with no net change in a Form 4 filed 2026-10-15. 0001796226-26-000002
Accepted , ingested